Viewing Study NCT05395650


Ignite Creation Date: 2025-12-24 @ 5:09 PM
Ignite Modification Date: 2025-12-26 @ 7:55 PM
Study NCT ID: NCT05395650
Status: UNKNOWN
Last Update Posted: 2023-02-15
First Post: 2022-05-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cyanocobalamin as Photosensitizing Agent
Sponsor: EL Romany Ophthalmics Factory
Organization:

Study Overview

Official Title: Cyanocobalamin as Photosensitizing Agent Using to Make Cross-linking to Cornea Collagen in Treatment of Progressive Keratoconus
Status: UNKNOWN
Status Verified Date: 2023-02
Last Known Status: NOT_YET_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: is cyanocobalamin active as Photosensitizing Agent instead of riboflavin ? using cyanocobalamin with mix of external collagen to make crosslinking with cornea collagen to make rigid of cornea
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: